CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Clinical trial NCT07337785 · RECRUITING

Trial details

NCT number: NCT07337785
Sponsor: Tongji Hospital
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Relapsing or Refractory Multiple Sclerosis (MS)Myasthenia Gravis (MG)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Autoimmune Encephalitis (AE)

Start date: 2025-12-12
Primary completion: 2026-12-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.